OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
February 12, 2024
Webinar Date/Time: Tue, Mar 5, 2024 2:00 PM EST
February 09, 2024
Webinar Date/Time: Thu, Mar 7, 2024 10:00 AM EST
February 07, 2024
Purolite and Repligen have commercially launched a new CH1 affinity resin for the purification of specialized mAbs.
February 05, 2024
Novo Holdings has entered into a merger agreement with Catalent and will acquire Catalent in a deal valued at $16.5 billion.
Webinar Date/Time: Fri, Feb 23, 2024 11:00 AM EST
February 03, 2024
The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.
Technical, regulatory, and personnel considerations characterize pharmaceutical compounding.
February 02, 2024
Effective analytics will eliminate failures, deviations, and non-conformances.
Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.
Given its positioning at each new year’s commencement, the J.P. Morgan Healthcare conference helps establish the tone with which the pharmaceutical industry is viewed.